Fever-Tree boosted by second half results up by nearly 50%

By Erin Smith

Published: 23 January, 2015

Fever-Tree, the premium mixer company, announced yesterday a strong financial performance in the second half of 2014, with sales expected to rise 43% and revenue to grow 49% to £34.7 million.

"We are encouraged to report such a strong trading statement, our first as a public company. Fever-Tree continues to trade well, buoyed by a strong festive period and growth in all of our regions and we look to the future with confidence," said Tim Warrillow, the chief executive officer of Fever-Tree.

Sales in the UK were particularly strong throughout the Christmas period, which is expected to push the full year revenue up 59% compared to the 2013 fiscal year.

The US market also helped to contribute to the strong sales and revenue growth with strong trading period during the that last quarter particularly throughout Thanksgiving and Christmas period.

Europe was also up for the second half of 2014 and revenue is expected to rise 35% for the region.

The rest of the world is expected to see sales rise by 58% over the 2013 fiscal year.

Fever-Tree stock rose 6.5% yesterday following the announcement.

The company's financial year-end was December 31, 2014 and the final fiscal year results are expected to be released in April 2015.

The strong financial performance is all good news for the relatively new publicly traded company, which was valued after yesterday's trading at over £240 million. A colossal climb from when the company first began trading on the Aim in early November 2014. The initial offering at the time valued the company at £154 million.

Fever-Tree has also benefited from the renaissance of gin that has occurred in recent years and particularly the rise in popularity of premium gins. Last year gin grew by 6% in 2014 to just over £358 million. Premium gin was helping to drive sales in the sector, which were up 19% year-on-year.

Printer friendly version